DRUG:AU:AU- (AUD)

ETF | Others |

Last Closing

USD 7.54

Change

+0.04 (+0.53)%

Market Cap

USD 0.17B

Volume

0.07M
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-28 )

Largest Industry Peers for Others

ETFs Containing DRUG:AU

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -4.07% 12% F 44% F
Dividend Return 0.35% 10% F 5% F
Total Return -3.72% 11% F 43% F
Trailing 12 Months  
Capital Gain -11.29% 7% C- 43% F
Dividend Return 2.94% 41% F 32% F
Total Return -8.35% 6% D- 43% F
Trailing 5 Years  
Capital Gain 13.21% 35% F 59% D-
Dividend Return 10.99% 24% F 21% F
Total Return 24.20% 27% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 5.32% 60% D- 56% F
Dividend Return 7.26% 59% D- 56% F
Total Return 1.94% 54% F 38% F
Risk Return Profile  
Volatility (Standard Deviation) 8.49% 62% D 91% A-
Risk Adjusted Return 85.47% 75% C 92% A
Market Capitalization 0.17B 32% F 64% D

Annual Financials (AUD)

Quarterly Financials (AUD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.